Skip to main content
Startup brings on 2 industry veterans as it preps for blood cancer trial

Notable Labs, a cancer drug testing startup, has named two industry veterans as part of its executive lineup: Hiroomi Tada, formerly from Incyte, as chief medical officer and Lloyd Mackenzie, previously of Aquinox Pharmaceuticals, as chief development officer. Notable is collaborating with the University of Kansas Cancer Center's Institute for Advancing Medical Innovation as it prepares to launch its first trial for its lead candidate ND-1000, a treatment for adult and pediatric patients with blood cancers.

Full Story: